ms and tirzepatide Treatment in Southaven, Every GLP-1 receptor agonist on
Description
Based on clinical data, the average weight loss is more than 15% of the starting body weight, while with semaglutide at highest amounts, the average weight loss is only 1012%
Source in comments
Marketed as Mounjaro, this once-weekly subcutaneous injection has demonstrated consistent reductions in both systolic and diastolic blood pressure across major clinical trials
Proc Am Thorac Soc 5(2):185192
